NL-OMON33152
Withdrawn
Not Applicable
Effectiveness of inhalated corticosteroids in preschool children following hospital admission for acute dyspnea and wheeze - ICS@ADP
Isala Klinieken0 sites62 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Episodic viral wheeze
- Sponsor
- Isala Klinieken
- Enrollment
- 62
- Status
- Withdrawn
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion criteria
- •\- Children that are admitted to the paediatric ward of the Isala Klinieken in Zwolle for the first time with acute dyspnea and wheezing.
- •\- Age 1 \- 4 years.
- •\- Child and parents must understand the Dutch language well
- •\- Informed consent
Exclusion Criteria
- •Exclusion criteria
- •\- Previous use of medication different than short\-acting β2\-agonists before hospital admission
- •\- Proven RSV bronchiolitis
- •\- Crackles during auscultation of the lungs (suspective for RSV bronchiolitis)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Effectiveness of inhaled corticosteroids in preschool children following hospital admission for acute dyspnea and wheeze - ICS@ADPDyspnea and wheeze in young children:Symptoms of dyspnea and wheeze occur frequently in young children. Most wheezing episodes in preschool children are associated with viral upper respiratory tract infections. The majority of children have become asymptomatic by the age of 6 years. About one in three preschool children with recurrent wheeze continue to wheeze after the age of six years, and these children are usually diagnosed with asthma.MedDRA version: 12.0Level: LLTClassification code 10003553Term: AsthmaEUCTR2009-009579-36-NL
Completed
Not Applicable
Prevention of thunderstorm asthmaThunderstorm asthma.AsthmaIRCT2016102520828N2Ahvaz Jundishapur University of Medical Sciences54
Completed
Phase 3
Does inhaled corticosteroid predispose asthmatic patients to diabetes?Chronic lower respiratory diseases.AsthmaIRCT201605247411N2Ahvaz Jundishapur University of Medical Science28
Recruiting
Phase 1
Effect of Corton on olfactory dysfunction in COVID-19 patientsIRCT20200522047542N1Mashhad University of Medical Sciences70
Completed
Not Applicable
Checking of response to inhaled corticosteroid treatment on a new laboratory parameter (blood CD28) in patients of asthmaHealth Condition 1: J454- Moderate persistent asthmaCTRI/2015/07/005977ady Hardinge Medical College80